OncoSil doses first patient with OncoSilTM to advance pancreatic cancer treatment trials
OncoSil Medical (ASX:OSL), in its ongoing mission to develop treatments for pancreatic…
Oncosil Medical Ltd (ASX:OSL)
About Oncosil Medical Ltd
Key Information
OSL In the News
ASX Announcements
| Date | Announcement | File | Views |
|---|---|---|---|
| 17/04/2024 | Two more PANCOSIL Trial treatments using OncoSil device | 158.85KB | 4.4K |
| 16/04/2024 | Price Sensitive PS First patient treated with OncoSil device in Turkiye | 200.86KB | 2.0K |
| 16/04/2024 | Notice of Extraordinary General Meeting/Proxy Form | 435.73KB | 217 |
| 12/04/2024 | Price Sensitive PS First patient treated in the UK for the TRIPP-FXX study | 250.74KB | 4.5K |
| 09/04/2024 | UK Private Insurer Approves Reimbursement for OncoSil | 187.45KB | 5.4K |
| 05/04/2024 | Price Sensitive PS First Austria-based treatments utilising the OncoSil device | 360.47KB | 9.4K |
| 04/04/2024 | Dispatch of Entitlement Offer Prospectus | 242.33KB | 593 |
| 28/03/2024 | Notice under section 708A | 146.57KB | 223 |